SRRK
NasdaqSCHOLAR ROCK HOLDING CORP
Basic Materials · Biological Products, (No Diagnostic Substances)
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
🔒 price chart needs market-data feed$20.5M
2019
$15.4M
2020
$18.8M
2021
$33.2M
2022
$0
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$0
Net Income—
Gross Profit—
Oper Income$-384.6M
EPS (dil)$-3.29
Rev/sh$0.00
FCF/sh$-2.51
Book/sh$2.05
Gross M—
Oper M—
Profit M—
FCF M—
ROE—
ROA—
ROIC-1647.8%
R&D/Rev—
Rev Y/Y—
Rev 3Y CAGR-100.0%
EPS Y/Y-33.2%
EPS 3Y CAGR—
FCF 3Y CAGR—
Payout—
Div/sh—
Shs Chg Y/Y+14.9%
Current Ratio6.95
Quick Ratio—
Debt/Eq0.41
Int Coverage-55.8×
Net Debt$227.0M cash
Total Debt$100.3M
Cash & Eq$327.3M
Total Assets$404.3M
Oper CF$-300.0M
Capex$602,000
Free CF$-300.6M
Buybacks—
Equity$245.5M
Liabilities$158.8M
Shs Outstand0.12B
SectorBasic Materials
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $20.5M | $15.4M | $18.8M | $33.2M | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | $-54.5M | $-86.9M | $-129.9M | $-134.4M | $-384.6M |
| Net Income | $-51.0M | $-86.5M | $-131.8M | $-134.5M | $-377.9M |
| Diluted EPS | $-1.85 | $-2.81 | $-3.59 | $-2.26 | $-3.29 |
| Operating Cash Flow | $-63.1M | $-60.3M | $-126.8M | $-132.7M | $-300.0M |
| Free Cash Flow | $-66.2M | $-64.4M | $-132.0M | $-133.8M | $-300.6M |
COMMUNITY · $SRRK0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.